All Publications

Publications for all Oxford Principal Investigators within the CAMS Oxford Institute are included here, please use the search functions for publications related to specific Principal Investigators.

HSV-1 employs UL56 to antagonize expression and function of cGAMP channels

Blest HTW. et al, (2024), Cell Reports, 43, 114122 - 114122

Impact of maternal risk factors on ethnic disparities in maternal mortality: a national population-based cohort study

Vousden N. et al, (2024), The Lancet Regional Health - Europe, 40

Oncogenic mutations of KRAS modulate its turnover by the CUL3/LZTR1 E3 ligase complex

Damianou A. et al, (2024), Life Science Alliance, 7, e202302245 - e202302245

Risk factors for labour induction and augmentation: a multicentre prospective cohort study in India

CHENG TS. et al, (2024), The Lancet Regional Health - Southeast Asia

The pRb/RBL2-E2F1/4-GCN5 axis regulates cancer stem cell formation and G0 phase entry/exit by paracrine mechanisms.

Chang C-H. et al, (2024), Nat Commun, 15

Proximity proteomics reveals UCH-L1 as an essential regulator of NLRP3-mediated IL-1β production in human macrophages and microglia.

Liang Z. et al, (2024), Cell Rep, 43

Publisher Correction: Semaphorin 3A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8+ T cells.

Barnkob MB. et al, (2024), Nat Commun, 15

Multi-omics analysis reveals COVID-19 vaccine induced attenuation of inflammatory responses during breakthrough disease.

Drury RE. et al, (2024), Nat Commun, 15

Type I interferon regulation by USP18 is a key vulnerability in cancer

Jové V. et al, (2024), iScience, 27

No evidence of difference in mortality with amoxicillin versus co-amoxiclav for hospital treatment of community-acquired pneumonia

Wei J. et al, (2024), Journal of Infection

A Report on the Safety of Acitretin Use in Renal Failure Patients on Hemodialysis

Shim PJ. et al, (2024), Clinical and Experimental Dermatology

Semmaphorin 3 A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8+ T cells.

Barnkob MB. et al, (2024), Nat Commun, 15

Can AlphaFold's breakthrough in protein structure help decode the fundamental principles of adaptive cellular immunity?

McMaster B. et al, (2024), Nature methods

Emerging variants develop total escape from potent monoclonal antibodies induced by BA.4/5 infection.

Liu C. et al, (2024), Nature communications, 15

High-dose corticosteroid therapy in COVID-19: the RECOVERY trial - Authors' reply.

Peto L. et al, (2024), Lancet (London, England), 403, 1339 - 1340

Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease

Liew F. et al, (2024), Nature Immunology, 25, 607 - 621

Perinatal outcomes after admission with COVID-19 in pregnancy: a UK national cohort study.

Engjom HM. et al, (2024), Nature communications, 15

Research Highlights

Bilici M. et al, (2024), Transplantation, 108

Unconventional human CD61 pairing with CD103 promotes TCR signaling and antigen-specific T cell cytotoxicity

Hamid MHBA. et al, (2024), Nature Immunology

Structure and function of Semaphorin-5A glycosaminoglycan interactions

Nagy GN. et al, (2024), Nature Communications, 15

Cookies on this website

All Publications